Early molecular causes of pathological cardiac hypertrophy and failure

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1052659

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pathological increase in heart size is a common condition in Australia. Small regulatory RNAs are now known to have a role in the normal development of the heart. Therefore we want to identify and then test the use of small RNA molecules as prevention and therapy for heart enlargement in an animal model. We will also identify different combinations of changes in the DNA sequence that could be used as markers for the predisposition of increased heart.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $311,860.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiac hypertrophy | gene expression | genotype | microrna | prevention

Related Links